ADMA - ADMA Biologics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
21,368
16,985
22,761
10,661
7,178
Cost of Revenue
38,955
42,195
29,164
6,361
4,311
Gross Profit
-17,586
-25,209
-6,404
4,300
2,866
Operating Expenses
Research Development
2,796
3,926
6,230
7,688
7,016
Selling General and Administrative
24,952
22,503
18,093
8,495
6,746
Total Operating Expenses
32,559
35,080
32,061
16,183
13,762
Operating Income or Loss
-50,145
-60,289
-38,465
-11,883
-10,896
Interest Expense
7,700
5,523
3,286
2,240
1,843
Total Other Income/Expenses Net
1,410
-127
-2,066
-5,443
-5,269
Income Before Tax
-55,756
-65,743
-43,759
-19,515
-17,970
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-55,756
-65,743
-43,759
-19,515
-17,970
Net Income
-55,756
-65,743
-43,759
-19,515
-17,970
Net Income available to common shareholders
-55,756
-65,743
-43,759
-19,515
-17,970
Reported EPS
Basic
-
-1.45
-1.91
-1.61
-1.73
Diluted
-
-1.45
-1.91
-1.61
-1.73
Weighted average shares outstanding
Basic
-
45,189
22,896
12,153
10,412
Diluted
-
45,189
22,896
12,153
10,412
EBITDA
-
-56,774
-37,781
-16,806
-15,657